ArticleBMJ open diabetes research & care2020

Therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and lobeglitazone in drug-naïve patients with type 2 diabetes: initial triple study.

Soo Lim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.